person

Mª Pilar M. S.

Country
Spain
Department
Hematología

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
89
Sites with multiple studies

Has run more than one trial at 89 of 231 partner sites.

Specializations

Hematologic Oncology

The investigator specializes in treating acute myeloid leukemia (AML), with particular focus on molecular and genetic variations of the disease. Their research encompasses novel therapeutic approaches for different genetic subtypes of AML.

  • KMT2A/MLL gene alterations
  • NPM1 mutations
  • NUP98 gene variations
  • FLT3-ITD negative AML

The investigator's work explores targeted therapeutic interventions combined with standard treatment protocols.

Targeted Therapies

The investigator focuses on developing and evaluating targeted therapeutic agents for hematologic malignancies. Their research includes assessment of novel compounds in combination with conventional chemotherapy regimens.

  • SNDX-5613 applications
  • Quizartinib treatment
  • Combination therapy approaches
  • Maintenance therapy protocols

Their work emphasizes personalized treatment strategies based on specific genetic markers.

Treatment Innovation

The investigator's research encompasses innovative treatment paradigms in hematologic oncology, focusing on improving survival outcomes through targeted interventions.

  • Intensive chemotherapy protocols
  • Induction therapy optimization
  • Consolidation strategies
  • Long-term maintenance approaches

Their work integrates molecular diagnostics with therapeutic decision-making.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.